“I owe a lot to the AAOA and the fellowship process. Obtaining that level of expertise improved my patient outcomes greatly and made me and my practice more marketable. I was asked about my allergy practice/fellowship at several job interviews…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here: